The EvA study: Aims and strategy

European Respiratory Journal

Volumn 40, Issue 4, 2012, Pages 823-829

  Ziegler Heitbrock, Loems ^a   Frankenberger, Marion ^b   Heimbeck, Irene ^a   Burggraf, Dorothe ^a   Wjst, Matthias ^b   Häussinger, Karl ^a   Brightling, Chris ^c   Gupta, Sumit ^c   Parr, David ^d   Subramanian, Deepak ^d   Singh, Dave ^e   Kolsum, Umme ^e   Boschetto, Piera ^f   Potena, Alfredo ^f   Gorecka, Dorota ^g   Nowinski, Adam ^g   Barta, Imre ^h   Döme, Balazs ^h   Strausz, Janos ^h,i   Greulich, Timm ^j   Vogelmeier, Claus ^j   Bals, Robert ^k   Hohlfeld, Jens M ^l   Welte, Tobias ^m   Venge, Per ⁿ   Gut, Ivo ^o   Boland, Anne ^p   Olaso, Robert ^p   Hager, Jörg ^p   Hiemstra, Pieter ^q   Rabe, Klaus F ^r   Unmußig, Martina ^s   Müller Quernheim, Joachim ^s   Prasse, Antje ^s   more..

^a ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY OF FERRARA   (Italy)

^g NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^h NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j UNIVERSITY HOSPITAL MARBURG   (Germany)

^k SAARLAND UNIVERSITY   (Germany)

^l FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^m HANNOVER MEDICAL SCHOOL   (Germany)

ⁿ UPPSALA UNIVERSITY   (Sweden)

^o National Institute of Bioinformatics   (Spain)

^p CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^q LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^r UNIVERSITY OF KIEL   (Germany)

^s UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

Airway inflammation; Bronchoalveloar lavage; Computed tomography; Emphysema

Indexed keywords

ANTIBIOTIC AGENT; GLUCOCORTICOID;

ARTICLE; BLOOD SAMPLING; BRONCHOSCOPY; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISEASE MARKER; EUROPEAN UNION; EVA STUDY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; INSPIRATORY CAPACITY; LUNG DENSITY; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MOLECULAR DIAGNOSIS; NOMENCLATURE; OXYGEN TENSION; PATHOPHYSIOLOGY; PATIENT SELECTION; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; RESIDUAL VOLUME; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT PARAMETERS; SIGNAL TRANSDUCTION; SMOKING; STEROID THERAPY; STUDY DESIGN; THICKNESS; TOTAL LUNG CAPACITY;

AGED; BRONCHIAL DISEASES; BRONCHOSCOPY; CASE-CONTROL STUDIES; GENE EXPRESSION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; MIDDLE AGED; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84867122301     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00142811     Document Type: Article

References (24)

1. Rodriguez-Roisin R. Global Initiative for Chronic Obstructive Lung Disease. www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management. html Date last updated: December 2011. Date last accessed: January 2012.
2. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931. (Pubitemid 41598207)
3. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-721. (Pubitemid 39140629)
4. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672-688. (Pubitemid 37258549)
5. Mason RJ, Buist AS, Fisher EB, et al. Cigarette smoking and health. Am Rev Respir Dis 1985; 132: 1133-1136. (Pubitemid 16221411)
6. Burrows B, Knudson RJ, Cline MG, et al. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977; 115: 195-205. (Pubitemid 8036155)
7. Smith KR. National burden of disease in India from indoor air pollution. Proc Natl Acad Sci USA 2000; 97: 13286-13293.
8. Orozco-Levi M, Garcia-Aymerich J, Villar J, et al. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 542-546. (Pubitemid 43372528)
9. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648. (Pubitemid 8124466)
10. Khoury MJ, Beaty TH, Tockman MS, et al. Familial aggregation in chronic obstructive pulmonary disease: use of the loglinear model to analyze intermediate environmental and genetic risk factors. Genet Epidemiol 1985; 2: 155-166. (Pubitemid 15027436)
11. Patel BD, Coxson HO, Pillai SG, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 500-505.
12. Silverman EK, Vestbo J, Agusti A, et al. Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD 2011; 8: 121-135.
13. Hayhurst MD, MacNee W, Flenley DC, et al. Diagnosis of pulmonary emphysema by computerised tomography. Lancet 1984; 2: 320-322. (Pubitemid 14054822)
14. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278: 1355-1360.
15. Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72: 1016-1023.
16. Nakano Y, Wong JC, de Jong PA, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 2005; 171: 142-146. (Pubitemid 40105413)
17. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162: 1102-1108.
18. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 1309-1315. (Pubitemid 43900704)
19. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008; 31: 869-873.
20. Regan EA, Hokanson JE, Murphy JR, et al. Genetic Epidemiology of COPD (COPDGene) study design. COPD 2010; 7: 32-34.
21. 1- antitrypsin deficiency. Eur Respir J 2009; 33: 1345-1353.
22. Dirksen A. Monitoring the progress of emphysema by repeat computed tomography scans with focus on noise reduction. Proc Am Thorac Soc 2008; 5: 925-928.
23. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 1987; 42: 241-249. (Pubitemid 17058936)
24. Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 418-424. (Pubitemid 36216426)